Pratik Bhagunde

Statistics

Publications

Citations

382

H-Index

Active since

2010

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Houston

Sanofi (United States)

Pratik Bhagunde is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, pharmacokinetics of antimicrobials, and antibiotic resistance.

Publications per year

2010–2019

Publications

Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model

Jin Wu, Fred Racine, Michael K. Wismer et al. · Antimicrobial Agents and Chemotherapy · 2018 · 64 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Population Pharmacokinetic Analysis for Imipenem–Relebactam in Healthy Volunteers and Patients With Bacterial Infections

Pratik Bhagunde, Parul Patel, Mallika Lala et al. · CPT Pharmacometrics & Systems Pharmacology · 2019 · 60 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Novel Modeling Framework To Guide Design of Optimal Dosing Strategies for β-Lactamase Inhibitors

Pratik Bhagunde, Kai-Tai Chang, Elizabeth B. Hirsch et al. · Antimicrobial Agents and Chemotherapy · 2012 · 59 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants

Elizabeth G. Rhee, Matthew L. Rizk, Nicole Calder et al. · Antimicrobial Agents and Chemotherapy · 2018 · 57 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

A translational pharmacokinetic/pharmacodynamic model to characterize bacterial kill in the presence of imipenem-relebactam

Pratik Bhagunde, Zufei Zhang, Fred Racine et al. · International Journal of Infectious Diseases · 2019 · 47 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

1–5 of 11